AptaBio Therapeutics (Korea) Price on November 18, 2024
293780 Stock | 6,590 310.00 4.94% |
If you're considering investing in AptaBio Stock, it is important to understand the factors that can impact its price. As of today, the current price of AptaBio Therapeutics stands at 6,590, as last reported on the 26th of November, with the highest price reaching 6,910 and the lowest price hitting 6,300 during the day. AptaBio Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0891, which signifies that the company had a -0.0891% return per unit of risk over the last 3 months. AptaBio Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AptaBio Therapeutics' Mean Deviation of 3.11, risk adjusted performance of (0.07), and Standard Deviation of 4.15 to double-check the risk estimate we provide.
AptaBio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
AptaBio |
Sharpe Ratio = -0.0891
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 293780 |
Estimated Market Risk
4.14 actual daily | 36 64% of assets are more volatile |
Expected Return
-0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AptaBio Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AptaBio Therapeutics by adding AptaBio Therapeutics to a well-diversified portfolio.
AptaBio Therapeutics Valuation on November 18, 2024
It is possible to determine the worth of AptaBio Therapeutics on a given historical date. On November 18, 2024 AptaBio was worth 6310.0 at the beginning of the trading date compared to the closed value of 6340.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of AptaBio Therapeutics stock. Still, in general, we apply an absolute valuation method to find AptaBio Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of AptaBio Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against AptaBio Therapeutics' related companies.
Open | High | Low | Close | Volume | |
6,390 | 6,680 | 6,140 | 6,310 | 78,506 | |
11/18/2024 | 6,310 | 6,450 | 6,210 | 6,340 | 79,018 |
6,280 | 6,470 | 6,220 | 6,230 | 69,123 |
Backtest AptaBio Therapeutics | | | AptaBio Therapeutics History | | | AptaBio Therapeutics Valuation | Previous | Next |
AptaBio Therapeutics Trading Date Momentum on November 18, 2024
On November 19 2024 AptaBio Therapeutics was traded for 6,230 at the closing time. The highest price during the trading period was 6,470 and the lowest recorded bid was listed for 6,220 . The volume for the day was 69.1 K. This history from November 19, 2024 contributed to the next trading day price decline. The daily price change to the next closing price was 1.74% . The overall trading delta to the current price is 0.63% . |
AptaBio Therapeutics Fundamentals Correlations and Trends
By evaluating AptaBio Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among AptaBio Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. AptaBio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About AptaBio Therapeutics Stock history
AptaBio Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AptaBio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AptaBio Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AptaBio Therapeutics stock prices may prove useful in developing a viable investing in AptaBio Therapeutics
AptaBio Therapeutics Stock Technical Analysis
AptaBio Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
AptaBio Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
AptaBio Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on KOSDAQ. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
AptaBio Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how AptaBio Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AptaBio Therapeutics shares will generate the highest return on investment. By undertsting and applying AptaBio Therapeutics stock market strength indicators, traders can identify AptaBio Therapeutics entry and exit signals to maximize returns
AptaBio Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for AptaBio Therapeutics' price direction in advance. Along with the technical and fundamental analysis of AptaBio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AptaBio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.07) | |||
Jensen Alpha | (0.35) | |||
Total Risk Alpha | (1.07) | |||
Treynor Ratio | 0.715 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for AptaBio Stock analysis
When running AptaBio Therapeutics' price analysis, check to measure AptaBio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AptaBio Therapeutics is operating at the current time. Most of AptaBio Therapeutics' value examination focuses on studying past and present price action to predict the probability of AptaBio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AptaBio Therapeutics' price. Additionally, you may evaluate how the addition of AptaBio Therapeutics to your portfolios can decrease your overall portfolio volatility.
Commodity Directory Find actively traded commodities issued by global exchanges | |
CEOs Directory Screen CEOs from public companies around the world |